“STUDY ON SAFETY AND EFFECTIVENESS OF ORAL TOFACITINIB IN PATIENTS WITH REFRACTORY MODERATE TO SEVERE ATOPIC DERMATITIS”. International Research Journal of Pharmacy 9, no. 8 (August 30, 2018): 125–128. Accessed May 31, 2026. https://irjponline.org/index.php/irjp/article/view/3224.